These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

441 related items for PubMed ID: 16914140

  • 1. Complex formation between tissue transglutaminase II (tTG) and vascular endothelial growth factor receptor 2 (VEGFR-2): proposed mechanism for modulation of endothelial cell response to VEGF.
    Dardik R, Inbal A.
    Exp Cell Res; 2006 Oct 01; 312(16):2973-82. PubMed ID: 16914140
    [Abstract] [Full Text] [Related]

  • 2. Molecular mechanisms underlying the proangiogenic effect of factor XIII.
    Dardik R, Loscalzo J, Eskaraev R, Inbal A.
    Arterioscler Thromb Vasc Biol; 2005 Mar 01; 25(3):526-32. PubMed ID: 15618543
    [Abstract] [Full Text] [Related]

  • 3. Vascular endothelial growth factor receptor-1 and receptor-2 initiate a phosphatidylinositide 3-kinase-dependent clonogenic response in acute myeloid leukemia cells.
    List AF, Glinsmann-Gibson B, Stadheim C, Meuillet EJ, Bellamy W, Powis G.
    Exp Hematol; 2004 Jun 01; 32(6):526-35. PubMed ID: 15183893
    [Abstract] [Full Text] [Related]

  • 4. Parathyroid hormone-related protein (107-139) increases human osteoblastic cell survival by activation of vascular endothelial growth factor receptor-2.
    Alonso V, de Gortázar AR, Ardura JA, Andrade-Zapata I, Alvarez-Arroyo MV, Esbrit P.
    J Cell Physiol; 2008 Dec 01; 217(3):717-27. PubMed ID: 18651620
    [Abstract] [Full Text] [Related]

  • 5. Contact inhibition of VEGF-induced proliferation requires vascular endothelial cadherin, beta-catenin, and the phosphatase DEP-1/CD148.
    Grazia Lampugnani M, Zanetti A, Corada M, Takahashi T, Balconi G, Breviario F, Orsenigo F, Cattelino A, Kemler R, Daniel TO, Dejana E.
    J Cell Biol; 2003 May 26; 161(4):793-804. PubMed ID: 12771128
    [Abstract] [Full Text] [Related]

  • 6. An autocrine loop directed by the vascular endothelial growth factor promotes invasiveness of human melanoma cells.
    Lacal PM, Ruffini F, Pagani E, D'Atri S.
    Int J Oncol; 2005 Dec 26; 27(6):1625-32. PubMed ID: 16273219
    [Abstract] [Full Text] [Related]

  • 7. Vascular endothelial growth factor receptor-1 promotes migration and invasion in pancreatic carcinoma cell lines.
    Wey JS, Fan F, Gray MJ, Bauer TW, McCarty MF, Somcio R, Liu W, Evans DB, Wu Y, Hicklin DJ, Ellis LM.
    Cancer; 2005 Jul 15; 104(2):427-38. PubMed ID: 15952180
    [Abstract] [Full Text] [Related]

  • 8. Interactions between sphingosine-1-phosphate and vascular endothelial growth factor signalling in ML-1 follicular thyroid carcinoma cells.
    Balthasar S, Bergelin N, Löf C, Vainio M, Andersson S, Törnquist K.
    Endocr Relat Cancer; 2008 Jun 15; 15(2):521-34. PubMed ID: 18509004
    [Abstract] [Full Text] [Related]

  • 9. VEGF and VEGFR-2 (KDR) internalization is required for endothelial recovery during wound healing.
    Santos SC, Miguel C, Domingues I, Calado A, Zhu Z, Wu Y, Dias S.
    Exp Cell Res; 2007 May 01; 313(8):1561-74. PubMed ID: 17382929
    [Abstract] [Full Text] [Related]

  • 10. Vascular endothelial growth factor acts in an autocrine manner in rhabdomyosarcoma cell lines and can be inhibited with all-trans-retinoic acid.
    Gee MF, Tsuchida R, Eichler-Jonsson C, Das B, Baruchel S, Malkin D.
    Oncogene; 2005 Dec 01; 24(54):8025-37. PubMed ID: 16116481
    [Abstract] [Full Text] [Related]

  • 11. Ganglioside GM3 inhibits VEGF/VEGFR-2-mediated angiogenesis: direct interaction of GM3 with VEGFR-2.
    Chung TW, Kim SJ, Choi HJ, Kim KJ, Kim MJ, Kim SH, Lee HJ, Ko JH, Lee YC, Suzuki A, Kim CH.
    Glycobiology; 2009 Mar 01; 19(3):229-39. PubMed ID: 18974200
    [Abstract] [Full Text] [Related]

  • 12. Activation of fractalkine/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischaemia.
    Ryu J, Lee CW, Hong KH, Shin JA, Lim SH, Park CS, Shim J, Nam KB, Choi KJ, Kim YH, Han KH.
    Cardiovasc Res; 2008 May 01; 78(2):333-40. PubMed ID: 18006432
    [Abstract] [Full Text] [Related]

  • 13. Variable effects of alpha v suppression on VEGFR-2 expression in endothelial cells of different vascular beds.
    Dardik R, Livnat T, Seligsohn U.
    Thromb Haemost; 2009 Nov 01; 102(5):975-82. PubMed ID: 19888537
    [Abstract] [Full Text] [Related]

  • 14. Colocalization of the VEGF-R2 and the common IL-3/GM-CSF receptor beta chain to lipid rafts leads to enhanced p38 activation.
    Saulle E, Riccioni R, Coppola S, Parolini I, Diverio D, Riti V, Mariani G, Laufer S, Sargiacomo M, Testa U.
    Br J Haematol; 2009 May 01; 145(3):399-411. PubMed ID: 19245429
    [Abstract] [Full Text] [Related]

  • 15. Non-redundant roles of the Gab1 and Gab2 scaffolding adapters in VEGF-mediated signalling, migration, and survival of endothelial cells.
    Caron C, Spring K, Laramée M, Chabot C, Cloutier M, Gu H, Royal I.
    Cell Signal; 2009 Jun 01; 21(6):943-53. PubMed ID: 19233262
    [Abstract] [Full Text] [Related]

  • 16. Differential regulation of vascular endothelial growth factor receptors (VEGFR) revealed by RNA interference: interactions of VEGFR-1 and VEGFR-2 in endothelial cell signaling.
    Kou R, SenBanerjee S, Jain MK, Michel T.
    Biochemistry; 2005 Nov 15; 44(45):15064-73. PubMed ID: 16274253
    [Abstract] [Full Text] [Related]

  • 17. Alzheimer's beta-amyloid peptide blocks vascular endothelial growth factor mediated signaling via direct interaction with VEGFR-2.
    Patel NS, Mathura VS, Bachmeier C, Beaulieu-Abdelahad D, Laporte V, Weeks O, Mullan M, Paris D.
    J Neurochem; 2010 Jan 15; 112(1):66-76. PubMed ID: 19818105
    [Abstract] [Full Text] [Related]

  • 18. Insulin-like growth factor binding protein-7 (IGFBP7) blocks vascular endothelial cell growth factor (VEGF)-induced angiogenesis in human vascular endothelial cells.
    Tamura K, Hashimoto K, Suzuki K, Yoshie M, Kutsukake M, Sakurai T.
    Eur J Pharmacol; 2009 May 21; 610(1-3):61-7. PubMed ID: 19374835
    [Abstract] [Full Text] [Related]

  • 19. Vascular endothelial growth factor-mediated decrease in plasma soluble vascular endothelial growth factor receptor-2 levels as a surrogate biomarker for tumor growth.
    Ebos JM, Lee CR, Bogdanovic E, Alami J, Van Slyke P, Francia G, Xu P, Mutsaers AJ, Dumont DJ, Kerbel RS.
    Cancer Res; 2008 Jan 15; 68(2):521-9. PubMed ID: 18199548
    [Abstract] [Full Text] [Related]

  • 20. Decursin and decursinol angelate inhibit VEGF-induced angiogenesis via suppression of the VEGFR-2-signaling pathway.
    Jung MH, Lee SH, Ahn EM, Lee YM.
    Carcinogenesis; 2009 Apr 15; 30(4):655-61. PubMed ID: 19228635
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.